Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Rheumatology (Oxford, England)|October 5, 2017
Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up dataAnoek A E de Joode, Jan Stephan F Sanders, Xavier Puéchal, et al.Annals of the Rheumatic Diseases|November 27, 2010
Long-term patient survival in ANCA-associated vasculitisOliver Flossmann, Annelies Berden, Kirsten de Groot, et al.Annals of the Rheumatic Diseases|December 16, 2006
EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitisBernhard Hellmich, Oliver Flossmann, Wolfgang L Gross, et al.Annals of the Rheumatic Diseases|January 29, 2013
The characterisation and determinants of quality of life in ANCA associated vasculitisNeil Basu, Andrew McClean, Lorraine Harper, et al.Rheumatology (Oxford, England)|June 7, 2013
Explaining fatigue in ANCA-associated vasculitisNeil Basu, Andrew McClean, Lorraine Harper, et al.Rheumatology (Oxford, England)|December 16, 2010
A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitisRavi Suppiah, Chetan Mukhtyar, Oliver Flossmann, et al.Rheumatology (Oxford, England)|February 4, 2014
Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitisNeil Basu, Andrew McClean, Lorraine Harper, et al.Annals of the Rheumatic Diseases|December 1, 2011
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-upLorraine Harper, Matthew D Morgan, Michael Walsh, et al.The Journal of Rheumatology|June 7, 2007
The future of damage assessment in vasculitisPhilip Seo, Raashid A Luqmani, Oliver Flossmann, et al.Journal of the American Society of Nephrology : JASN|December 16, 2016
Thrombotic Microangiopathy in Inverted Formin 2<i>-</i>Mediated Renal DiseaseRachel C Challis, Troels Ring, Yaobo Xu, et al.Pageof 4